Enforced Expression of the Transcriptional Coactivator OBF1 Impairs B Cell Differentiation at the Earliest Stage of Development

por Bordon, Alain, Bosco, Nabil, Du Roure, Camille, Bartholdy, Boris, Kohler, Hubertus, Matthias, Gabriele, Rolink, Antonius G., Matthias, Patrick
Publicado 2008

Hematopoietic Overexpression of FOG1 Does Not Affect B-Cells but Reduces the Number of Circulating Eosinophils

por Du Roure, Camille, Versavel, Aude, Doll, Thierry, Cao, Chun, Pillonel, Vincent, Matthias, Gabriele, Kaller, Markus, Spetz, Jean-François, Kopp, Patrick, Kohler, Hubertus, Müller, Matthias, Matthias, Patrick
Publicado 2014

The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study

por Rosenkranz, Stephan, Channick, Richard, Chin, Kelly M., Jenner, Bartosz, Gaine, Sean, Galiè, Nazzareno, Ghofrani, Hossein‐Ardeschir, Hoeper, Marius M., McLaughlin, Vallerie V., Du Roure, Camille, Rubin, Lewis J., Sitbon, Olivier, Tapson, Victor, Lang, Irene M.
Publicado 2021

Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension

por Coghlan, J. Gerry, Gaine, Sean, Channick, Richard, Chin, Kelly M., du Roure, Camille, Gibbs, J. Simon R., Hoeper, Marius M., Lang, Irene M., Mathai, Stephen C., McLaughlin, Vallerie V., Mitchell, Lada, Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F., Galiè, Nazzareno
Publicado 2023